Safety and effectiveness of lenalidomide in Japanese patients with relapsed/refractory ATLL: post-marketing surveillance. Miyazaki T, Uno S, Fujimori H, Motegi Y, et al. Int J Hematol 2025;121:79-88.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Miyazaki T, Uno S, Fujimori H, Motegi Y, et al. Safety and effectiveness of lenalidomide in Japanese patients with relapsed/refractory ATLL: post-marketing surveillance. Int J Hematol 2025;121:79-88.
PMID: 39570473